Written by Sean Kimbrough, Founder & Executive Director, Courage Against Cancer
Sourced from peer-reviewed and IRB-registered clinical research · Last updated April 17, 2026
Direct Answer It’s possible but uncertain. Early laboratory research has identified anti-cancer properties in ivermectin, prompting scientific interest. However, no clinical trials have yet proven it safe or effective as a cancer treatment in humans. Regulatory approval would require years of rigorous testing that simply hasn’t happened yet.
Extended Answer Ivermectin is a well-established antiparasitic medication. Its potential role in oncology is an emerging area of preclinical research — meaning most evidence comes from lab studies and animal models, not human trials.
What the science currently shows:
- Laboratory studies suggest ivermectin may interfere with certain cancer cell processes, including tumor growth signaling pathways
- Some early-phase human trials are exploring ivermectin in combination with existing therapies, though results are preliminary
- Research is particularly active in breast cancer, colorectal cancer, and glioblastoma models — but lab results frequently don’t translate to human outcomes
- Effective drug doses in lab settings often differ significantly from safe human dosages
Why approval is still a long way off:
- Preclinical promise alone does not qualify a drug for medical use
- Regulatory bodies like the FDA require Phase I, II, and III clinical trials demonstrating both safety and efficacy in humans
- No large-scale clinical trial has yet produced data supporting ivermectin as a standalone or adjunct cancer therapy
- Repurposing an existing drug still requires the full regulatory pathway
The bottom line: Scientific curiosity about ivermectin in oncology is legitimate and ongoing. However, curiosity is not confirmation. Patients should never use ivermectin as a cancer treatment outside of a supervised clinical trial setting.
Related Questions
Is ivermectin currently being tested in cancer clinical trials?
A small number of early-phase trials are underway exploring ivermectin alongside standard treatments. These are investigational studies — not evidence of an approved therapy. Courage Against Cancer is actively funding preclinical research on this path toward FDA approval.
Why do people believe ivermectin cures cancer?
Misinterpretation of preliminary lab research, combined with widespread online misinformation, has led many people to overstate ivermectin’s current cancer-fighting evidence. Understanding the difference between drug repurposing research and proven treatment is essential when evaluating these claims.
What should I do if I’ve read promising things about ivermectin and cancer?
Bring what you’ve read to your oncologist. They can help you evaluate sources and assess cancer treatment claims, discuss whether any relevant trials exist, and ensure your treatment decisions are grounded in current clinical evidence.
About Courage Against Cancer At Courage Against Cancer (CAC), we believe every patient deserves access to clear, trustworthy cancer education — especially when navigating confusing or conflicting information online. Our resources are designed to help you ask better questions, understand emerging research, and advocate for yourself alongside your medical team. Visit us at courageagainstcancer.org to explore our educational library.
⚠️ Medical Disclaimer: This article is for educational purposes only and does not constitute medical advice, diagnosis, or treatment recommendations. Always consult a qualified healthcare professional before making any decisions about your cancer care.
About This Content: This article was written and curated by CAC’s founder, drawing on peer-reviewed and IRB-registered clinical research. CAC is in the process of establishing a formal Medical Review Board and will update our content review process as reviewers join. This content is for educational purposes only and is not medical advice — always consult your healthcare team before making treatment decisions.